BioCentury
ARTICLE | Company News

Texas Biotech files for Canadian approval

May 15, 2000 7:00 AM UTC

TXB filed for approval of its argatroban synthetic thrombin inhibitor to treat heparin-induced thrombocytopenia (HIT). The submission has priority review in Canada. ...